Update on GPCR-based targets for the development of novel antidepressants
Sign Up to like & getrecommendations! Published in 2021 at "Molecular Psychiatry"
DOI: 10.1038/s41380-021-01040-1
Abstract: Traditional antidepressants largely interfere with monoaminergic transport or degradation systems, taking several weeks to have their therapeutic actions. Moreover, a large proportion of depressed patients are resistant to these therapies. Several atypical antidepressants have been… read more here.
Keywords: based targets; gpcr based; update gpcr; development ... See more keywords
Neutrophils and Macrophages as Targets for Development of Nanotherapeutics in Inflammatory Diseases
Sign Up to like & getrecommendations! Published in 2020 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics12121222
Abstract: Neutrophils and macrophages are major components of innate systems, playing central roles in inflammation responses to infections and tissue injury. If they are out of control, inflammation responses can cause the pathogenesis of a wide… read more here.
Keywords: neutrophils macrophages; macrophages targets; inflammatory diseases; development nanotherapeutics ... See more keywords